Claim: Clinical trial data for Pfizer's maternal vaccine to protect babies from RSV support the vaccine's safety and efficacy, according to a vote by an FDA advisory committee. The FDA could soon approve the vaccine. But a popular social media post makes misleading claims about the trial findings.
Fact-check: Instagram Post Misleads About Pfizer's RSV Maternal Vaccine - FactCheck.org
Verdict: clinical trial data for pfizer's maternal vaccine to protect babies from rsv support the vaccine's safety and efficacy, according to a vote by an fda advisory committee. the fda could soon approve the vaccine. but a popular social media post makes misleading claims about the trial findings.
Organisation: FactCheck.org
Author: Lori Robertson
Date published: 2023-06-12T16:49:52